|
DE60039715D1
(de)
|
1999-11-19 |
2008-09-11 |
Csl Ltd |
Hcv-impfstoff zusammensetzungen
|
|
PT1284740E
(pt)
|
2000-05-19 |
2008-07-09 |
Corixa Corp |
Tratamento profiláctico e terapêutico de doenças infecciosas, autoimunes e alérgicas com compostos à base de monossacáridos
|
|
EP1382352A1
(de)
|
2002-07-19 |
2004-01-21 |
GBF Gesellschaft für Biotechnologische Forschung mbH |
Bisacyloxypropylcystein-Konjugate und deren Verwendung
|
|
US7569225B2
(en)
|
2002-08-12 |
2009-08-04 |
The Council Of The Queensland Institute Of Medical Research |
Immunogenic lipopeptides comprising T-helper and B-cell epitopes
|
|
ES2535451T3
(es)
|
2002-08-12 |
2015-05-11 |
The Council Of The Queensland Institute Of Medical Research |
Nuevos lipopéptidos inmunógenos que comprenden epítopos de linfocitos T auxiliares y de linfocitos T citotóxicos (CTL)
|
|
EP1550458A1
(en)
|
2003-12-23 |
2005-07-06 |
Vectron Therapeutics AG |
Synergistic liposomal adjuvants
|
|
US20060002941A1
(en)
|
2004-01-23 |
2006-01-05 |
Vievax Corp. |
Compositions comprising immune response altering agents and methods of use
|
|
WO2005079419A2
(en)
|
2004-02-17 |
2005-09-01 |
The Regents Of The University Of California |
Methods of treating immunopathological disorders
|
|
GB0405634D0
(en)
|
2004-03-12 |
2004-04-21 |
Univ Southampton |
Anti-virus therapy for respiratory diseases
|
|
GB0411411D0
(en)
|
2004-05-21 |
2004-06-23 |
Glaxosmithkline Biolog Sa |
Vaccines
|
|
KR20070068460A
(ko)
|
2004-10-18 |
2007-06-29 |
글로브이뮨 |
만성 c형 간염에 대한 효모계 치료
|
|
EP1666056A1
(en)
|
2004-12-06 |
2006-06-07 |
Bestewil Holding B.V. |
Cancer vaccine vesicles
|
|
NZ556004A
(en)
|
2004-12-21 |
2010-05-28 |
Vaxinnate Corp |
Compositions of influenza viral proteins comprising at least one flagellin and at least one influenza M2 protein
|
|
EP1861426A4
(en)
|
2005-02-08 |
2008-11-12 |
Queensland Inst Med Res |
IMMUNOGENOUS MOLECULES
|
|
WO2006091591A1
(en)
|
2005-02-22 |
2006-08-31 |
The Regents Of The University Of California |
Methods of treating gastrointestinal inflammation
|
|
EP1787660A1
(en)
*
|
2005-11-22 |
2007-05-23 |
GBF Gesellschaft für Biotechnologische Forschung mbH |
New adjuvants on the basis of bisacyloxypropylcysteine conjugates and their uses in pharmaceutical compositions
|
|
ES2555544T3
(es)
|
2006-03-07 |
2016-01-04 |
Vaxinnate Corporation |
Composiciones que incluyen hemaglutinina, métodos de preparación y métodos de uso de las mismas
|
|
WO2008085549A2
(en)
|
2006-07-28 |
2008-07-17 |
Board Of Regents Of The University Of Texas System |
Compositions and methods for stimulation of lung innate immunity
|
|
AU2014202674B2
(en)
*
|
2007-05-04 |
2014-08-14 |
Marina Biotech, Inc. |
Amino acid lipids and uses thereof
|
|
EP2200638B1
(en)
|
2007-10-09 |
2016-03-16 |
The University of Melbourne |
Compositions for the transfection of cells
|
|
WO2009137103A2
(en)
|
2008-05-09 |
2009-11-12 |
Ourth Donald D |
Anti-cancer/anti-viral compounds and methods of use
|
|
US8728465B2
(en)
|
2008-06-17 |
2014-05-20 |
Cedars-Sinai Medical Center |
Use of toll-like receptor ligands as adjuvants to vaccination therapy for brain tumors
|
|
US20110171259A1
(en)
|
2008-09-05 |
2011-07-14 |
Martin Gagne |
Novel Compositions and Adjuvants
|
|
KR20110117705A
(ko)
|
2009-02-11 |
2011-10-27 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
톨-유사 수용체 조정제 및 질병의 치료
|
|
KR101856462B1
(ko)
|
2009-03-25 |
2018-05-10 |
보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 |
병원체에 대한 포유동물의 선천성 면역 저항성의 자극을 위한 조성물
|
|
WO2010115229A1
(en)
|
2009-04-09 |
2010-10-14 |
The University Of Melbourne |
Immunogenic composition and uses thereof
|
|
GB0907989D0
(en)
|
2009-05-08 |
2009-06-24 |
Hybrid Systems Ltd |
Multivalent adjuvant display
|
|
EP2338521A1
(en)
|
2009-12-28 |
2011-06-29 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Lipopeptide- and lipoprotein-conjugates and its use
|
|
EA031379B1
(ru)
*
|
2010-03-23 |
2018-12-28 |
Новартис Аг |
Соединения (липопептиды на основе цистеина) и композиции в качестве агонистов tlr2, применяемые для лечения инфекционных, воспалительных, респираторных и других заболеваний
|
|
CA2811957C
(en)
|
2010-09-22 |
2019-04-16 |
The University Of Melbourne |
Soluble tlr2 moiety for use in the treatment or prevention of respiratory conditions associated with infectious agents
|
|
IN2014CN02581A
(cg-RX-API-DMAC7.html)
*
|
2011-10-06 |
2015-08-07 |
Immunovaccine Technologies Inc |
|
|
CN105555756B
(zh)
|
2013-06-28 |
2018-12-07 |
奥克兰联合服务有限公司 |
氨基酸缀合物和肽缀合物及缀合方法
|
|
US20170274068A1
(en)
|
2014-09-12 |
2017-09-28 |
The University Of Melbourne |
Immunological reagent
|
|
WO2016044839A2
(en)
|
2014-09-19 |
2016-03-24 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
|
|
JP2016216593A
(ja)
|
2015-05-19 |
2016-12-22 |
株式会社リコー |
反応材、熱交換器及びケミカルヒートポンプ
|
|
EP3328418A1
(en)
|
2015-07-29 |
2018-06-06 |
Novartis AG |
Combination therapies comprising antibody molecules to pd-1
|
|
TW201735952A
(zh)
|
2016-02-26 |
2017-10-16 |
瑪格蕾特 安 布萊博 |
胺基酸及肽共軛物以及共軛過程
|
|
AU2018241248B2
(en)
|
2017-03-31 |
2025-01-23 |
Ena Respiratory Pty Ltd |
Treatment of respiratory infection with a TLR2 agonist
|
|
NL2018803B1
(en)
*
|
2017-04-27 |
2018-11-05 |
Academisch Ziekenhuis Leiden Handelend Onder De Naam Leids Univ Medisch Centrum/ H O D N Lumc |
Adjuvant compounds
|
|
EP3676250A4
(en)
*
|
2017-08-30 |
2021-05-26 |
Auckland Uniservices Limited |
PEPTIDE CONJUGATES, CONJUGATION METHODS AND USES THEREOF
|
|
IL275360B2
(en)
|
2017-12-21 |
2023-10-01 |
Axelia Oncology Pty Ltd |
Optimal compounds
|
|
WO2019119069A1
(en)
|
2017-12-21 |
2019-06-27 |
Ena Therapeutics Pty Ltd |
Administration of a tlr2 agonist for the treatment or prevention of a respiratory condition associated with an infectious agent
|
|
JP2022546806A
(ja)
|
2019-09-04 |
2022-11-09 |
アクセリア オンコロジー ピーティーワイ リミテッド |
癌免疫療法
|
|
WO2021042174A1
(en)
|
2019-09-04 |
2021-03-11 |
Ena Therapeutics Pty Ltd |
Cancer treatment
|
|
AU2021278377A1
(en)
|
2020-05-26 |
2022-12-15 |
Ena Respiratory Pty Ltd |
Treatment of coronavirus
|